Historic Day: FDA Updates Hormone Therapy Labeling
A major milestone has just been reached in women’s health policy. The U.S. FDA and Department of Health and Human Services (HHS) have officially modernized the labeling of menopausal hormone therapy — finally moving beyond decades of outdated, fear-based messaging. This update recognizes what evidence-based clinicians have long understood: boxed warnings are meant for life-threatening risks — not for standard hormone therapy. It’s a historic moment that reframes how both clinicians and patients can approach hormone therapy with clarity and confidence.
